Nutex Health (NUTX) FY2025 10-K Risk Factors: 20 New, 15 Dropped

What the changes say

Nutex added substantial risk disclosures regarding the No Surprises Act, arbitration partner HaloMD lawsuits, short seller reports, and securities class actions.
Former doctor owner share issuances, potential dilution, and valuation disputes dominate the new additions.

What changed since the prior 10-K

New

NewRisks Related to Nutex Health Inc
Regulatory and litigation uncertainty under the No Surprises Act may reduce our cash collections and increase dispute costs
Regulatory uncertainty and updates to the Federal IDR portal under the No Surprises Act may reduce cash collections and increase dispute costs.
NewRisks Related to Nutex Health Inc
Our third party provider in the federal and state arbitration process, HaloMD, has been, and may in the future be, subject to lawsuits filed by health insurance providers, which may have an adverse impact on our revenues, reputation, financial condition and the trading price of our common stock
Our third-party arbitration provider, HaloMD, which submitted 50-60% of our medical claims in 2025, faces lawsuits from health insurance providers that could impact our revenues.
NewRisks Related to Nutex Health Inc
Nutex has no contractual right to access or audit HaloMD’s proprietary benchmarking data or documents prepared and submitted by HaloMD to the IDREs on behalf of the Company, such as petitions, position statements, methodology formulas, payment demand letters and arbitration briefs
Nutex has no contractual right to audit HaloMD, whose practices were targeted in a July 2025 short seller report based on insurer lawsuits.
NewRisks Related to Nutex Health Inc
Sales of a substantial amount of our Common Stock by our stockholders, or the perception that such sales could occur, could cause the price of our Common Stock to fall
Sales of common stock by affiliates, including CEO Dr. Vo, could cause our stock price to fall.
NewRisks Related to Nutex Health Inc
Our obligation to issue additional shares of our common stock to former doctor owners of under construction hospitals may cause significant dilution of the voting power of our current stockholders
Issuing additional shares to former doctor owners of under-construction hospitals could significantly dilute existing stockholders' voting power.
NewRisks Related to Nutex Health Inc
With respect to seven hospitals, the initial 24-month operational periods expired on or prior to December 31, 2025. Based on the formula described above, and assuming an aggregate 1,361,861 shares issued, the earn out shares will represent approximately 19.2% of outstanding shares as of December 31, 2025
Former owners of certain under-construction hospitals dispute the number of earn-out shares issuable, contesting adjustments made for 2024 reverse stock splits.
NewRisks Related to Nutex Health Inc
Short sellers of our stock may be manipulative and may drive down the market price of our common stock
Short sellers may publish negative opinions and drive down the market price of our common stock.
NewRisks Related to Nutex Health Inc
We may be subject to risks of litigation and disputes
We face litigation risks, including a putative class action filed on August 22, 2025, in the Southern District of Texas alleging federal securities law violations.
NewRisks Related to Nutex Health Inc
For the year ended December 31, 2024, we identified material weaknesses in our internal control over financial reporting. These material weaknesses that were previously disclosed as of December 31, 2024 were remediated as of December 31, 2025
Material weaknesses identified in internal controls over financial reporting for 2024 were remediated as of December 31, 2025, but future weaknesses could harm our stock price.
NewRisks Related to Nutex Health Inc
The Company may have to record impairments in the future, which could materially adversely affect its reported financial results and negatively impact the trading value of its Common Stock
If unable to generate sufficient cash, borrow, or sell equity, we may not be able to execute our capital-intensive business plans.
NewRisks Related to Nutex Health Inc
We experienced operating losses in 2023 and could incur operating losses in the future as we implement our business plans. We anticipate making significant capital expenditures for the foreseeable future as we expand our business, including the development of new hospital facilities and acquisition of additional IPAs
We experienced operating losses in 2023 and anticipate significant capital expenditures to develop new hospitals and acquire IPAs.
NewRisks Related to Our Business and Industry
Ultimate amounts collected may differ from anticipated collections, and, as a result, may impact our ability to generate revenue at expected levels
An unstable U.S. economy and public health emergencies could negatively impact our ability to generate revenue at expected levels.
NewRisks Related to Our Business and Industry
As a front-line provider of health care services, we have been and will be affected by the health and economic effects of public health emergencies such as COVID-19
NewRisks Related to Our Business and Industry
The Physician LLCs are owned by the doctors providing services to the corresponding hospital, provide physician and provider services to the hospitals, and employ the doctors and other providers
NewRisks Related to Our Business and Industry
controlling healthcare costs, and such efforts, including any revisions to reimbursement policies, may further reduce, complicate or delay our reimbursement claims
NewRisk Related to our Population Health Management Division
New California privacy regulations require Automated Decision-Making Technology (“ADMT”) transparency and future cybersecurity audits
NewRisk Related to our Population Health Management Division
Heightened scrutiny of Medicare Advantage risk-adjustment practices may increase audit and repayment risk
NewRisks Related to Our Legal and Regulatory Environment
Changes to Stark Law DHS codes and exception thresholds may increase compliance risk
NewRisks Related to Our Legal and Regulatory Environment
HIPAA rule changes may require operational and documentation updates and raise enforcement exposure
NewRisks Related to Our Legal and Regulatory Environment
Escalating cyber threats and regulatory expectations may increase costs and disruption risk

Dropped

DroppedRisks Related to Nutex Health Inc
As of March 24, 2025, there were 5,528,448 shares of Common Stock outstanding, including 1,949,581 shares of Common Stock held by our affiliates, including our Chairman and Chief Executive Officer
Share counts and affiliate holdings as of March 24, 2025.
DroppedRisks Related to Nutex Health Inc
The laws and regulations applicable to public companies are complex and may require an increasing amount of our management’s time and increase staffing and compliance costs
DroppedRisks Related to Nutex Health Inc
Our business and the markets in which we operate are new and rapidly evolving, which makes it difficult to evaluate our prospects and the risks and challenges we may encounter
Complex public company regulations and SEC reporting obligations.
DroppedRisks Related to Nutex Health Inc
Our current business plans require a significant amount of capital. If we are unable to obtain sufficient funding or do not have access to capital, we may not be able to execute our business plans and our prospects, financial condition and results of operations could be materially adversely affected
Rapidly evolving business model and challenges in evaluating prospects.
DroppedRisks Related to Our Business and Industry
Recovery of certain out of network claims under the arbitration process is subject to change, and our arbitration success rate could be subject to a significant and sustained decline
Capital requirements and operating losses in 2022 and 2023.
DroppedRisks Related to Our Business and Industry
Public health emergencies could negatively affect our operations, business and financial condition, and our ability to generate revenue could be negatively impacted if the U.S. economy remains unstable for a significant amount of time
DroppedRisks Related to Our Business and Industry
Our growth depends in part on our ability to identify and develop successful new geographies, physician partners and patients. If we are not able to successfully execute upon our growth strategies, there may be a material adverse effect on our business, financial condition, cash flows and results of operations
DroppedRisks Related to Our Business and Industry
geography, are subject to significant uncertainty, and are based on assumptions and estimates that may not prove to be accurate. The estimates and forecasts in this prospectus relating to the size and expected growth of the market for our services, and the estimates of our market opportunity may prove to be inaccurate
Uncertainty in recovering out-of-network claims under the arbitration process.
DroppedRisks Related to Our Business and Industry
Any future litigation against us could be costly and time-consuming to defend
DroppedRisk Related to our Population Health Management Division
We could incur substantial costs in protecting or defending our intellectual property rights, and any failure to protect our intellectual property could adversely affect our business, results of operations and financial condition
DroppedRisk Related to our Population Health Management Division
Assertions by third parties of infringement or other violations by us of their intellectual property rights could result in significant costs and harm our business and operating results
DroppedRisk Related to our Population Health Management Division
The information that we expect to provide to our clients could be inaccurate or incomplete, which could harm our business reputation, financial condition, and results of operations
COVID-19 and public health emergency operational impacts.
DroppedRisk Related to our Population Health Management Division
Our proprietary applications may not operate properly, which could damage our reputation, give rise to a variety of claims against us, or divert our resources from other purposes, any of which could harm our business and operating results
DroppedRisks Related to Our Common Stock
We will continue to incur significantly increased costs and devote substantial management time as a result of operating as a public company
Growth dependence on identifying new geographies and physician partners.
DroppedRisks Related to Our Common Stock
Even if our management concludes that our internal control over financial reporting is effective, our independent registered public accounting firm may issue a report that is qualified if it is not satisfied with our controls or the level at which our controls are documented, designed, operated or reviewed

Reworded

91% rewrittenRisks Related to Our Business and Industry
In his capacity as the co-owner of the real estate entities that lease the land and buildings to our hospital facilities, Dr. Vo, our Chairman, CEO and major stockholder, may have conflicts of interest with the Company and its public stockholders
Removed detailed explanatory text regarding debt and lease mechanics for Real Estate Entities leased by Dr. Vo.
61% rewrittenRisks Related to Our Business and Industry
Reimbursement methodology and timing for our medical services is subject to change, and the reimbursement amount that we receive for emergency services could be subject to a significant and sustained decline
Updated phrasing to state we have 'few contractual arrangements' rather than 'do not have any contractual arrangements' with insurance companies.
52% rewrittenRisks Related to Our Business and Industry
If we or our partner physicians or other healthcare providers fail to comply with applicable data interoperability and information blocking rules, our consolidated results of operations could be adversely affected
Maintained core disclosure regarding 21st Century Cures Act data interoperability rules with minor phrasing tweaks.
52% rewrittenRisks Related to Our Business and Industry
We rely on our management team and key employees and our business, financial condition, cash flows and results of operations could be harmed if we are unable to retain qualified personnel
Retained management retention risk language with minor stylistic adjustments.
49% rewrittenRisks Related to Nutex Health Inc
We may be required to take write-downs or write-offs, restructuring and impairment or other charges that could have a significant negative effect on our financial condition, results of operations and stock price, which could cause you to lose some or all of your investment
Maintained write-down and restructuring risk language without substantive alterations to the core threat.
47% rewrittenRisks Related to Our Business and Industry
We primarily depend on reimbursement by third-party payors, as well as payments by individuals, which could lead to delays and uncertainties in the timing and process of reimbursement, including any changes or reductions in Medicare reimbursement rates or rules
Retained third-party payor reimbursement and delay risks with minor punctuation updates.
44% rewrittenRisks Related to Our Business and Industry
Our estimates with respect to the claims processing by insurance companies and our resulting cash collections may differ from previous estimated results, and we may be required to make periodic adjustments to our estimation process for new facts or circumstances
Shortened the estimation process risk by removing the sentence regarding ultimate collection amounts differing from anticipated collections.

All 60 risk factors

Headings as the filing states them, in filing order.

Risks Related to Nutex Health Inc

01Regulatory and litigation uncertainty under the No Surprises Act may reduce our cash collections and increase dispute costsNew
02Our third party provider in the federal and state arbitration process, HaloMD, has been, and may in the future be, subject to lawsuits filed by health insurance providers, which may have an adverse impact on our revenues, reputation, financial condition and the trading price of our common stockNew
03Nutex has no contractual right to access or audit HaloMD’s proprietary benchmarking data or documents prepared and submitted by HaloMD to the IDREs on behalf of the Company, such as petitions, position statements, methodology formulas, payment demand letters and arbitration briefsNew
04Sales of a substantial amount of our Common Stock by our stockholders, or the perception that such sales could occur, could cause the price of our Common Stock to fallNew
05Our obligation to issue additional shares of our common stock to former doctor owners of under construction hospitals may cause significant dilution of the voting power of our current stockholdersNew
06With respect to seven hospitals, the initial 24-month operational periods expired on or prior to December 31, 2025. Based on the formula described above, and assuming an aggregate 1,361,861 shares issued, the earn out shares will represent approximately 19.2% of outstanding shares as of December 31, 2025New
07Short sellers of our stock may be manipulative and may drive down the market price of our common stockNew
08We may be subject to risks of litigation and disputesNew
09For the year ended December 31, 2024, we identified material weaknesses in our internal control over financial reporting. These material weaknesses that were previously disclosed as of December 31, 2024 were remediated as of December 31, 2025New
10We may be required to take write-downs or write-offs, restructuring and impairment or other charges that could have a significant negative effect on our financial condition, results of operations and stock price, which could cause you to lose some or all of your investment49% rewritten
11The Company may have to record impairments in the future, which could materially adversely affect its reported financial results and negatively impact the trading value of its Common StockNew
12We experienced operating losses in 2023 and could incur operating losses in the future as we implement our business plans. We anticipate making significant capital expenditures for the foreseeable future as we expand our business, including the development of new hospital facilities and acquisition of additional IPAsNew
13We may decide to close underperforming hospitals which may result in a temporary decrease in overall revenues
14We may experience difficulties in managing our growth and expanding our operations

Risks Related to Our Business and Industry

15Reimbursement methodology and timing for our medical services is subject to change, and the reimbursement amount that we receive for emergency services could be subject to a significant and sustained decline61% rewritten
16The estimates and assumptions we are required to make in connection with the preparation of our financial statements may prove to be inaccurate
17Our estimates with respect to the claims processing by insurance companies and our resulting cash collections may differ from previous estimated results, and we may be required to make periodic adjustments to our estimation process for new facts or circumstances44% rewritten
18Ultimate amounts collected may differ from anticipated collections, and, as a result, may impact our ability to generate revenue at expected levelsNew
19As a front-line provider of health care services, we have been and will be affected by the health and economic effects of public health emergencies such as COVID-19New
20We rely on our management team and key employees and our business, financial condition, cash flows and results of operations could be harmed if we are unable to retain qualified personnel52% rewritten
21In his capacity as the co-owner of the real estate entities that lease the land and buildings to our hospital facilities, Dr. Vo, our Chairman, CEO and major stockholder, may have conflicts of interest with the Company and its public stockholders91% rewritten
22The Physician LLCs are owned by the doctors providing services to the corresponding hospital, provide physician and provider services to the hospitals, and employ the doctors and other providersNew
23We primarily depend on reimbursement by third-party payors, as well as payments by individuals, which could lead to delays and uncertainties in the timing and process of reimbursement, including any changes or reductions in Medicare reimbursement rates or rules47% rewritten
24controlling healthcare costs, and such efforts, including any revisions to reimbursement policies, may further reduce, complicate or delay our reimbursement claimsNew
25Our business and growth strategy depend on our ability to maintain and expand facilities staffed with qualified physicians. If we are unable to do so, future growth would be limited and our business, operating results and financial condition would be harmed
26Our industry is competitive, and we expect it to attract increased competition. We currently face competition in various aspects of our business, including from a range of companies that provide similar services, including hospitals, managed service organizations and provider networks and data analysis consultants
27Developments affecting spending by the healthcare industry could adversely affect our business
28We and our physician partners and other healthcare professionals may become subject to medical liability claims, which could cause us to incur significant expenses and may require us to pay significant damages if the claims are not covered by insurance
29If we or our partner physicians or other healthcare providers fail to comply with applicable data interoperability and information blocking rules, our consolidated results of operations could be adversely affected52% rewritten
30Our business and operations could suffer in the event of material information technology system failures, security breaches, or other deficiencies in cybersecurity
31Actual or perceived failures to comply with applicable data protection, privacy and security laws, regulations, standards and other requirements, including contractual obligations, could adversely affect our business, financial condition and results of operations
32These privacy and security laws and regulations (including our contractual obligations) are constantly evolving, may conflict with each other, and can result in investigations, procedures, or actions that lead to significant civil and criminal penalties and operational restrictions
33Changes in U.S. tax laws, and the adoption of tax reform policies could adversely affect our operating results and financial condition
34Our quarterly results may fluctuate significantly, which could adversely impact the value of our Common Stock
35Any fluctuation in our quarterly results may not accurately reflect the underlying performance of our business and could cause a decline in the trading price of our Common Stock
36In addition, Nutex Holdco subsequently entered into guarantees of finance lease obligations of each of our hospitals and mortgage debt of Real Estate Entities affiliated with Dr. Vo, the Company’s Chairman and Chief Executive Officer
37The arrangements we have with our VIEs are not as secure as direct ownership of such entities
38Any failure by our affiliated entities or their owners to perform their obligations under their agreements with us would have a material adverse effect on our business, results of operations and financial condition
39If there is a change in accounting principles or the interpretation thereof affecting consolidation of VIEs, it could impact our consolidation of total revenues derived from our affiliated physician groups

Risk Related to our Population Health Management Division

40New physicians and other providers must be properly enrolled in governmental healthcare programs before we can receive reimbursement for their services, and there may be delays in the enrollment process
41We may have difficulty collecting payments from third-party payors in a timely manner
42Federal and state laws may limit our ability to collect monies owed by patients
43We have established reserves for our potential medical claim losses, which are subject to inherent uncertainties, and a deficiency in the established reserves may lead to a reduction in our assets or net incomes
44We do not have a Knox-Keene license
45If our affiliated physician group is not able to satisfy California financial solvency regulations, they could become subject to sanctions and their ability to do business in California could be limited or terminated
46Primary care physicians may seek to affiliate with our and our competitors’ IPAs at the same time
47If we inadvertently employ or contract with an excluded person, we may face government sanctions
48New California privacy regulations require Automated Decision-Making Technology (“ADMT”) transparency and future cybersecurity auditsNew
49Heightened scrutiny of Medicare Advantage risk-adjustment practices may increase audit and repayment riskNew

Risks Related to Our Legal and Regulatory Environment

50If any of our hospitals lose their regulatory licenses, permits and/or registrations, as applicable, or become ineligible to receive reimbursement from third-party payors, there may be a material adverse effect on our business, financial condition, cash flows, or results of operations
51If our arrangements with our partner physicians and other physician partners are found to constitute the improper rendering of medical services or fee splitting under applicable state laws, our business, financial condition and our ability to operate in those states could be adversely impacted
52We face inspections, reviews, audits and investigations under federal and state government programs and contracts. These audits could have adverse findings that may negatively affect our business, including our results of operations, liquidity, financial condition and reputation
53Recent healthcare regulations, and other changes in the healthcare industry and in healthcare spending may adversely affect our business, financial condition and results of operations
54Changes to Stark Law DHS codes and exception thresholds may increase compliance riskNew
55HIPAA rule changes may require operational and documentation updates and raise enforcement exposureNew
56Escalating cyber threats and regulatory expectations may increase costs and disruption riskNew

Risks Related to Our Common Stock

57Anti-takeover provisions under Delaware law could make an acquisition of the Company, which may be beneficial to the stockholders of the Company, more difficult and may prevent attempts by the stockholders to replace or remove management
58Because we have no current plans to pay cash dividends on our Common Stock for the foreseeable future, you may not receive any return on investment unless you sell your Common Stock for a price in excess of the purchase price
59The market price and trading volume of our Common Stock may be volatile and could decline significantly
60If securities or industry analysts do not publish research or publish inaccurate or unfavorable research about our business, the price and trading volume of our securities could decline

Other Nutex Health 10-Ks

FY2024 10-K risk factors
55 risks
Nutex Health faces heavy reliance on out-of-network emergency reimbursement and federal arbitration outcomes. The company depends on variable variable-interest entities and physician practices subject to strict corporate practice of medicine rules. Substantial debt guarantees and lease obligations tied to CEO-affiliated real estate entities create potential conflicts of interest and financial restrictions.
Filed Mar 31, 2025

About this page

The headings are the filing's own. The one-line readings and the overview are automated and can be wrong: read Item 1A of the 10-K for the exact wording.